Rosen Law Firm Encourages Investors to Act by April 15 Deadline in Securities Class Action Against TransMedics Group, Inc.

Sunday 6th of April 2025 20:36:00

TransMedics Group Inc. Investors: Important Deadline Approaches, Rosen Law Firm Encourages

New York, New York – Rosen Law Firm, a leading law firm dedicated to protecting investors, reminds investors that the deadline to file a motion to be included in the securities class action lawsuit against TransMedics Group Inc. is quickly approaching.

The lawsuit was filed in the United States District Court for the District of Massachusetts on behalf of investors who purchased TransMedics Group Inc. securities between April 28, 2020 and April 20, 2022. The lawsuit alleges that the company and its executives made false and misleading statements about the company's business, operations, and financial performance, causing investors to suffer significant losses.

The deadline to file a motion to be included in the lawsuit is May 24, 2022. Investors who purchased TransMedics Group Inc. securities during the class period and wish to be included in the lawsuit should contact the Rosen Law Firm immediately.

Rosen Law Firm founder and lead attorney, Laurence Rosen, stated, "We are committed to protecting the rights of investors and ensuring that they receive the compensation they deserve. We urge investors who suffered losses as a result of TransMedics Group Inc.'s alleged misconduct to contact us and learn more about their legal options."

The Rosen Law Firm has a proven track record of successfully representing investors in securities class action lawsuits. If you are an investor who purchased TransMedics Group Inc. securities during the class period and wish to learn more about your legal options, please contact the Rosen Law Firm at [insert contact information].

About Rosen Law Firm Rosen Law Firm is a leading law firm dedicated to protecting investors and ensuring that they receive the compensation they deserve. The firm has a proven track record of successfully representing investors in securities class action lawsuits. For more information, please visit our website at [insert website URL].